Point of Care Diagnostics Market - Global Industry Insights, and Forecast, 2022 - 2028

Point of Care Diagnostics Market - Global Industry Insights, and Forecast, 2022 - 2028

Cancer prevalence is increasing worldwide and often it is diagnosed in late stage, which affects the medical decision significantly. As cancer may be potentially cured if diagnosed in early stages, the importance of rapid point of care diagnostic tests is increasing in medical sector. Currently, cancer diagnosis is done by invasive techniques such as biopsy. Rapid biomarker identification tests are not present in extensive number. The U.S. Food & Drug Administration has approved breast cancer test in March 2018, offered by the company 23andMe. This cancer test is capable of diagnosing three of the 1000 mutations in the BRCA1 and BRCA2 genes associated with increased risk of breast, ovarian, and prostate cancer. Cancer point of care diagnostic/biomarker testing holds huge potential for market growth, as there is no significant competition in this sector.
Market Dynamics
Demand for point of care testing is increasing, owing to factors such as lack of access to centralized laboratories in emerging economies such as Asia Pacific, independence from centralized laboratories as the testing can be done on the spot without the need of laboratory facilities, and rapid diagnosis, which is expected to create significant demand for point of care diagnostics market. The market is expected to gain significant growth, owing to further developments in point-of-care diagnostics aimed towards impacting medical outcomes, increased adoption of rapid medical diagnostic devices, and rising prevalence of chronic diseases such as HIV, infectious diseases, and diabetes. Development of innovative point of care tests for wide number of applications is expected to fuel growth of the market. Product recalls in point of care diagnostics market and supply chain related issues in remote areas are expected to hinder the market growth
Key features of the study:

This report provides in-depth analysis of point of care diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global point of care diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Johnson & Johnson, Trinity Biotech Plc, and Siemens Healthineers.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care diagnostics market

Detailed Segmentation:

Global Point of Care Diagnostics Market, By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

Global Point of Care Diagnostics Market, By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

Global Point of Care Diagnostics Market, By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

Global Point of Care Diagnostics Market, By Geography:

North America

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

U.S.
Canada

Europe

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Technology:

Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors

By Application:

Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
DoA Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others

By End User:

Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Danaher Corporation*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Abbott Laboratories
Acon Laboratories, Inc.
Hoffman-La Roche Ltd.
Becton, Dickinson, and Company
Johnson & Johnson
Trinity Biotech Plc
Siemens Healthineers

 “*” marked represents similar segmentation in other categories in the respective section.